Weekly cisplatin fails to show fewer serious side effects in p16-negative head and neck cancer

Medical Xpress - latest medical and health news stories ·
Health & Medicine United Kingdom

Physicians typically use either a higher dose of cisplatin given every three weeks or a lower dose given weekly in combination with radiation to treat locally advanced head and neck cancer. However, before NRG-HN009, there was limited randomized evidence to determine which regimen provided the best balance of cancer control and treatment-related side effects.

Read original article on Medical Xpress - latest medical and health news stories →

Related news